INNV-14. PREDICTIVE UTILITY OF TEMOZOLOMIDE RESPONSE AS DETERMINED BY 3D EX-VIVO CELL CULTURE ASSAYS IN NEWLY DIAGNOSED GLIOBLASTOMA: A SINGLE INSTITUTION CASE SERIES EVALUATING PROGRESSION FREE SURVIVAL

Authors: Lindsay J Lipinski, Ajay Abad, Robert A Fenstermaker, Andrew J Fabiano, Dheerendra Prasad, Ashley M Smith, Matthew Gevaert, Teresa M DesRochers, Cecile Rose T Vibat

Published: 2021-11-18

DOI: 10.1093/neuonc/noab196.425

Source: Full article


Abstract

Abstract